Merrimack Pharmaceuticals Inc (MACK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 93,543 | 107,347 | 135,603 | 17,257 | 21,626 |
| Receivables | 100 | 190 | 43 | 43 | 275 |
| Other current assets | 0 | 0 | 0 | 26,634 | 33,295 |
| TOTAL | $95,046 | $115,577 | $141,563 | $46,272 | $57,435 |
| Non-Current Assets | |||||
| PPE Net | 6,467 | 10,188 | 11,178 | 12,852 | 14,212 |
| Investments And Advances | 10,551 | 11,400 | 0 | 0 | 0 |
| Other Non-Current Assets | 5,262 | 60,682 | 60,709 | 9,515 | 9,836 |
| TOTAL | $22,280 | $82,270 | $71,887 | $22,367 | $24,048 |
| Total Assets | $117,326 | $197,847 | $213,450 | $68,639 | $81,483 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,606 | 23,983 | 33,989 | 38,756 | 28,670 |
| Accrued Expenses | N/A | 6,613 | 13,530 | N/A | N/A |
| Other current liabilities | 2,171 | 2,117 | 2,077 | 69,241 | 59,552 |
| TOTAL | $19,777 | $34,557 | $57,737 | $107,997 | $88,222 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 49,884 | 48,906 | 218,041 | 216,861 |
| Other Non-Current Liabilities | 1,265 | 1,741 | 1,023 | 18,806 | 28,698 |
| TOTAL | $1,265 | $51,656 | $49,205 | $236,380 | $244,381 |
| Total Liabilities | $21,042 | $86,213 | $106,942 | $344,377 | $332,603 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,343 | 13,333 | 13,279 | 13,243 | 13,057 |
| Common Shares | 1,334 | 1,328 | 1,327 | 1,319 | 1,302 |
| Retained earnings | -482,771 | -469,820 | -472,922 | -984,485 | -954,799 |
| TOTAL | $96,284 | $111,634 | $106,508 | $-275,738 | $-251,120 |
| Total Liabilities And Equity | $117,326 | $197,847 | $213,450 | $68,639 | $81,483 |